| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11038485 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 508 journal articles in the PubMed database | Email to a friend | | |
| Findeisen R, Albrecht S, Richter B, et al.
Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer. [Journal Article]
Luminescence 2000 Sep-Oct; 15(5):283-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Findeisen R, Albrecht S, Richter B, et al.
Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer. [Comparative Study , Journal Article]
Clin Chem Lab Med 1998 Nov; 36(11):841-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nicolini A, Tartarelli G, Carpi A, et al.
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. [JOURNAL ARTICLE]
BMC Cancer 2006 Nov 20; 6(1):269.
Abstract | Full Citation | Find Related Articles | | Broll R, Erdmann H, Duchrow M, et al.
Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer? [Journal Article]
Eur J Surg Oncol 2001 Feb; 27(1):37-42.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gion M, Peloso L, Mione R, et al.
Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients. [Journal Article, Multicenter Study]
Cancer J 2001 May-Jun; 7(3):181-90.
Abstract | Full Citation | Find Related Articles | | Vizcarra E, Lluch A, Cibrián R, et al.
Value of CA 15.3 in breast cancer and comparison with CEA and TPA: a study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of the first metastasis. [Comparative Study , Journal Article]
Breast Cancer Res Treat 1996; 37(3):209-16.
Abstract | Full Citation | Find Related Articles | | Heer K, Kumar H, Read JR, et al.
Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. [Journal Article, Research Support, Non-U.S. Gov't]
Clin Cancer Res 2001 Nov; 7(11):3491-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Giovanella L, Ceriani L, Giardina G, et al.
Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). [Journal Article]
Clin Chem Lab Med 2002 Mar; 40(3):298-303.
Abstract | Full Citation | Find Related Articles | | Cooper BC, Ritchie JM, Broghammer CL, et al.
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. [Journal Article]
Clin Cancer Res 2002 Oct; 8(10):3193-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
